Dmitry Balyasny’s Telix Pharmaceuticals TLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$407K Buy
+37,124
New +$421K ﹤0.01% 2637

Other funds holding TLX

Dmitry Balyasny's TLX Position: Q3 2026 in Review

Dmitry Balyasny opened a new position in Telix Pharmaceuticals (TLX) in Q3 2026: 37,124 shares worth $407K. The stake represents ﹤0.01% of the portfolio and ranks #2637 among its holdings.

71 funds tracked by Wall St. Rank hold TLX as of Q3 2026.

  • Dmitry Balyasny held 37,124 shares of Telix Pharmaceuticals worth $407K as of Q3 2026.
  • Telix Pharmaceuticals was a new Dmitry Balyasny position in Q3 2026.
  • Telix Pharmaceuticals made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #2637 holding.
  • 71 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.